NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology
- PMID: 18783313
- PMCID: PMC2790033
- DOI: 10.1089/ars.2008.2220
NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology
Abstract
Reactive oxygen species (ROS) including superoxide (O(2)(.-)) and hydrogen peroxide (H(2)O(2)) are produced endogenously in response to cytokines, growth factors; G-protein coupled receptors, and shear stress in endothelial cells (ECs). ROS function as signaling molecules to mediate various biological responses such as gene expression, cell proliferation, migration, angiogenesis, apoptosis, and senescence in ECs. Signal transduction activated by ROS, "oxidant signaling," has received intense investigation. Excess amount of ROS contribute to various pathophysiologies, including endothelial dysfunction, atherosclerosis, hypertension, diabetes, and acute respiratory distress syndrome (ARDS). The major source of ROS in EC is a NADPH oxidase. The prototype phagaocytic NADPH oxidase is composed of membrane-bound gp91phox and p22hox, as well as cytosolic subunits such as p47(phox), p67(phox) and small GTPase Rac. In ECs, in addition to all the components of phagocytic NADPH oxidases, homologues of gp91(phox) (Nox2) including Nox1, Nox4, and Nox5 are expressed. The aim of this review is to provide an overview of the emerging area of ROS derived from NADPH oxidase and oxidant signaling in ECs linked to physiological and pathophysiological functions. Understanding these mechanisms may provide insight into the NADPH oxidase and oxidant signaling components as potential therapeutic targets.
Figures



Similar articles
-
Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase.Mol Cell Biochem. 2004 Sep;264(1-2):85-97. doi: 10.1023/b:mcbi.0000044378.09409.b5. Mol Cell Biochem. 2004. PMID: 15544038 Review.
-
Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.Circ Res. 2002 Dec 13;91(12):1160-7. doi: 10.1161/01.res.0000046227.65158.f8. Circ Res. 2002. Retraction in: Circ Res. 2014 Jan 17;114(2):e22. doi: 10.1161/01.res.0000441275.92652.60. PMID: 12480817 Retracted.
-
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.Cancer Lett. 2008 Jul 18;266(1):37-52. doi: 10.1016/j.canlet.2008.02.044. Epub 2008 Apr 10. Cancer Lett. 2008. PMID: 18406051 Free PMC article. Review.
-
Redox signaling in angiogenesis: role of NADPH oxidase.Cardiovasc Res. 2006 Jul 15;71(2):226-35. doi: 10.1016/j.cardiores.2006.04.015. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16781692 Review.
-
Bioluminescence imaging of NADPH oxidase activity in different animal models.J Vis Exp. 2012 Oct 22;(68):3925. doi: 10.3791/3925. J Vis Exp. 2012. PMID: 23117583 Free PMC article.
Cited by
-
Antioxidant Therapy: Is it your Gateway to Improved Cardiovascular Health?Pharm Anal Acta. 2015 Jan;6(1):323. doi: 10.4172/2153-2435.1000323. Pharm Anal Acta. 2015. PMID: 26005589 Free PMC article.
-
Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.BMJ Open. 2021 Apr 13;11(4):e037457. doi: 10.1136/bmjopen-2020-037457. BMJ Open. 2021. PMID: 33849844 Free PMC article.
-
NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.PLoS One. 2012;7(10):e48393. doi: 10.1371/journal.pone.0048393. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144758 Free PMC article.
-
Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge.Oxid Med Cell Longev. 2012;2012:132931. doi: 10.1155/2012/132931. Epub 2012 May 22. Oxid Med Cell Longev. 2012. PMID: 22685617 Free PMC article.
-
Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2.Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1670-80. doi: 10.1152/ajpregu.00445.2009. Epub 2009 Oct 14. Am J Physiol Regul Integr Comp Physiol. 2009. PMID: 19828841 Free PMC article.
References
-
- Abid MR. Spokes KC. Shih SC. Aird WC. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem. 2007;282:35373–35385. - PubMed
-
- Al–Mehdi AB. Zhao G. Dodia C. Tozawa K. Costa K. Muzykantov V. Ross C. Blecha F. Dinauer M. Fisher AB. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+ Circ Res. 1998;83:730–737. - PubMed
-
- Allingham MJ. van Buul JD. Burridge K. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol. 2007;179:4053–4064. - PubMed
-
- Ambasta RK. Kumar P. Griendling KK. Schmidt HH. Busse R. Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem. 2004;279:45935–45941. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous